Početna › Limfom › Washington › Seattle
Kliničke studije za Limfom u gradu Seattle, WA
12 studija za Limfom traži sudionike na lokacijama u gradu Seattle i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
U tijeku regrutacijaFaza 2
- Fred Hutchinson Cancer Center, Seattle
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
U tijeku regrutacijaFaza 2
- Fred Hutchinson Cancer Center, Seattle
Collection of Tissue Samples for Cancer Research
U tijeku regrutacijaOpažajna studija
- Fred Hutchinson, Seattle
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
- Seattle Children s Hospital, Seattle
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
U tijeku regrutacijaFaza 1/2
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
U tijeku regrutacijaFaza 1
- Fred Hutch Cancer Center, Seattle
DALY II USA/ MB-CART2019.1 for DLBCL
U tijeku regrutacijaFaza 2
- Fred Hutchinson Cancer Center, Seattle
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
U tijeku regrutacijaFaza 1/2
- Dren Investigational Site, Seattle
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
U tijeku regrutacijaOpažajna studija
- Seattle Children's Hospital, Seattle
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
U tijeku regrutacijaFaza 1/2
- University of Washington Medical Center, Seattle
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
U tijeku regrutacijaFaza 2
- Fred Hutchinson Cancer Center, Seattle
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
U tijeku regrutacijaFaza 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Studije za Limfom u drugim gradovima
- Houston, TX34 studija
- Boston, MA33 studija
- New York City, NY33 studija
- Washington, DC23 studija
- Baldwin Park, CA21 studija
- Chicago, IL20 studija
- Durham, NC17 studija
- St. Louis, MO15 studija
- Philadelphia, PA15 studija
- Cleveland, OH14 studija
- Edison, NJ12 studija
- Atlanta, GA12 studija
Ostale studije u gradu Seattle
- Nemikrocelularni karcinom pluća53 studija
- Rak (sve vrste)49 studija
- Rak prostate42 studija
- Akutna mijeloična leukemija40 studija
- Rak dojke39 studija
- Metastatski karcinom39 studija
- Kolorektalni rak34 studija
- Rak pluća33 studija
- Rak jajnika30 studija
- Multipli mijelom22 studija
- Mijelodisplastični sindromi21 studija
- Akutna limfoblastna leukemija21 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.